Abbott sold $2.1 billion worth of rapid COVID-19 tests in the last three months of 2021
by Lisa Schencker, Chicago Tribune
Jan 26, 2022
2 minutes
![](https://article-imgs.scribdassets.com/40kna3sxq89id859/images/file70WPSQJX.jpg)
As people across the country continue to grab at-home, COVID-19 tests off store shelves, Abbott Laboratories — the maker of one of the most popular of those tests — reported a stellar fourth quarter and financial year.
The north suburban-based company, which makes the BinaxNOW test and
You’re reading a preview, subscribe to read more.
Start your free 30 days